Central pontine myelinolysis historical perspective: Difference between revisions

	Central pontine myelinolysis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Central pontine myelinolysis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Central pontine myelinolysis historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Central pontine myelinolysis historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Central pontine myelinolysis historical perspective
CDC on Central pontine myelinolysis historical perspective
Central pontine myelinolysis historical perspective in the news
Blogs on Central pontine myelinolysis historical perspective
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Central pontine myelinolysis historical perspective

Revision as of 21:54, 24 July 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Central pontine myelinolysis was first discovered by Raymond Delacy Adams, an an American neurologist, in 1959.

Raymond Delacy Adams and colleagues observed a rapidly evolving quadriplegia and pseudobulbar palsy in a young alcoholic man whose postmortem examination showed a large, symmetrical, essentially demyelinative lesion occupying the greater part of the base of the pons In 1950.

Central pontine myelinolysis was first discovered by Raymond Delacy Adams, an an American neurologist, in 1959.

@@ Line 5: / Line 5: @@
 ==Overview==
+Central pontine myelinolysis was first discovered by '''Raymond Delacy Adams''', an an American [[neurologist]], in 1959.
 ==Historical Perspective==
 ===Discovery===
-* There is limited information about the historical perspective of [disease name].
-OR
-*[Disease name] was first discovered by [name of scientist], a [nationality + occupation], in [year]/during/following [event].
-*The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
-*In [year], [scientist] was the first to discover the association between [risk factor] and the development of [disease name].
-*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
-===Landmark Events in the Development of Treatment Strategies===
-===Impact on Cultural History===
+* '''Raymond Delacy Adams''' and colleagues observed a rapidly evolving [[quadriplegia]] and [[pseudobulbar palsy]] in a young alcoholic man whose postmortem examination showed a large, symmetrical, essentially [[Demyelination|demyelinative]] lesion occupying the greater part of the base of the [[pons]] In 1950.
-===Famous Cases===
+*Central pontine myelinolysis was first discovered by '''Raymond Delacy Adams''', an an American [[neurologist]], in 1959.
-The following are a few famous cases of [disease name]:
 ==References==